1218.74.01050 Boehringer Ingelheim Investigational Site
Buffalo, New York
We've found
7 trials
at this facility
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 1/9/2013
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
Status: Enrolling
Updated: 1/9/2013
Click here to add this to my saved trials

Asthma Clinical Trial
Updated: 4/4/2016
Efficacy and Safety of BI 655066 in Patients With Severe Persistent Asthma.
Status: Enrolling,
Phase
II
Updated: 4/4/2016
Click here to add this to my saved trials

Diabetes Mellitus, Type 1 Clinical Trial
Updated: 4/4/2016
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 4/4/2016
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Atrial Fibrillation Clinical Trial
Updated: 4/4/2016
Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)
Status: Enrolling,
Phase
IV
Updated: 4/4/2016
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 4/4/2016
BI 655066 Compared to Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 4/4/2016
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
Status: Enrolling,
Phase
III
Updated: 4/4/2016
Click here to add this to my saved trials
